West Pharmaceutical Services Inc (WST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, West Pharmaceutical Services Inc (WST) has a cash flow conversion efficiency ratio of 0.030x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($89.90 Million) by net assets ($2.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See West Pharmaceutical Services Inc (WST) balance sheet quality index to measure how much of total assets are equity-financed.
West Pharmaceutical Services Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how West Pharmaceutical Services Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check WST operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
West Pharmaceutical Services Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of West Pharmaceutical Services Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Partners Group Holding AG
SW:PGHN
|
0.271x |
|
Grasim Industries Limited
NSE:GRASIM
|
-0.049x |
|
Qnb Finansbank AS
IS:QNBTR
|
0.005x |
|
InterContinental Hotels Group PLC
LSE:IHG
|
-0.215x |
|
First Solar Inc
NASDAQ:FSLR
|
-0.022x |
|
Swiss Life Holding AG
SW:SLHN
|
0.155x |
|
Banco do Brasil S.A.
SA:BBAS3
|
0.201x |
|
Bayan Resources Tbk
JK:BYAN
|
0.092x |
Annual Cash Flow Conversion Efficiency for West Pharmaceutical Services Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of West Pharmaceutical Services Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see WST market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $3.18 Billion | $754.80 Million | 0.238x | -2.44% |
| 2024-12-31 | $2.68 Billion | $653.40 Million | 0.244x | -9.62% |
| 2023-12-31 | $2.88 Billion | $776.50 Million | 0.270x | -0.05% |
| 2022-12-31 | $2.68 Billion | $724.00 Million | 0.270x | +7.83% |
| 2021-12-31 | $2.34 Billion | $584.00 Million | 0.250x | -1.85% |
| 2020-12-31 | $1.85 Billion | $472.50 Million | 0.255x | +9.16% |
| 2019-12-31 | $1.57 Billion | $367.20 Million | 0.233x | -18.33% |
| 2018-12-31 | $1.01 Billion | $288.60 Million | 0.286x | +80.81% |
| 2017-12-31 | $1.67 Billion | $263.30 Million | 0.158x | -19.49% |
| 2016-12-31 | $1.12 Billion | $219.40 Million | 0.196x | -5.36% |
| 2015-12-31 | $1.02 Billion | $212.40 Million | 0.207x | +8.67% |
| 2014-12-31 | $958.10 Million | $182.90 Million | 0.191x | -21.53% |
| 2013-12-31 | $906.40 Million | $220.50 Million | 0.243x | -5.38% |
| 2012-12-31 | $728.90 Million | $187.40 Million | 0.257x | +28.83% |
| 2011-12-31 | $654.90 Million | $130.70 Million | 0.200x | -9.71% |
| 2010-12-31 | $625.70 Million | $138.30 Million | 0.221x | -7.04% |
| 2009-12-31 | $579.10 Million | $137.70 Million | 0.238x | -14.20% |
| 2008-12-31 | $487.10 Million | $135.00 Million | 0.277x | +5.30% |
| 2007-12-31 | $490.90 Million | $129.20 Million | 0.263x | -23.26% |
| 2006-12-31 | $419.30 Million | $143.80 Million | 0.343x | +33.86% |
| 2005-12-31 | $334.10 Million | $85.60 Million | 0.256x | +15.50% |
| 2004-12-31 | $310.60 Million | $68.90 Million | 0.222x | -17.42% |
| 2003-12-31 | $257.60 Million | $69.20 Million | 0.269x | +4.01% |
| 2002-12-31 | $208.70 Million | $53.90 Million | 0.258x | +39.64% |
| 2001-12-31 | $176.80 Million | $32.70 Million | 0.185x | -18.52% |
| 2000-12-31 | $214.10 Million | $48.60 Million | 0.227x | -24.12% |
| 1999-12-31 | $232.00 Million | $69.40 Million | 0.299x | -3.85% |
| 1998-12-31 | $228.20 Million | $71.00 Million | 0.311x | +27.81% |
| 1997-12-31 | $278.10 Million | $67.70 Million | 0.243x | -3.12% |
| 1996-12-31 | $252.30 Million | $63.40 Million | 0.251x | +38.62% |
| 1995-12-31 | $254.30 Million | $46.10 Million | 0.181x | -16.57% |
| 1994-12-31 | $229.20 Million | $49.80 Million | 0.217x | +12.31% |
| 1993-12-31 | $199.00 Million | $38.50 Million | 0.193x | +1.68% |
| 1992-12-31 | $178.70 Million | $34.00 Million | 0.190x | -30.97% |
| 1991-12-31 | $161.10 Million | $44.40 Million | 0.276x | +43.77% |
| 1990-12-31 | $187.80 Million | $36.00 Million | 0.192x | -15.64% |
| 1989-12-31 | $188.80 Million | $42.90 Million | 0.227x | -- |
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; sy… Read more